BioNTech, US agency enter into settlement agreement over COVID vaccine royalties-March 2024-www.financetom.com

BioNTech, US agency enter into settlement agreement over COVID vaccine royalties

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BioNTech, US agency enter into settlement agreement over COVID vaccine royalties

Dec 27, 2024 5:04 AM

Dec 27 (Reuters) - BioNTech said on Friday

that it had entered into a settlement agreement with the U.S.

National Institutes of Health over the payment of royalties and

other amounts related to its COVID-19 vaccine.

The German company said it would pay $791.5 million to the

U.S. agency as part of the settlement.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Anil

D'Silva)

Previous page： O-I Glass, GridBeyond to Deploy AI-Powered Battery Storage at UK Facility Next page： Airbus eyes operations at four Spirit Aero plants, sources say

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

O-I Glass, GridBeyond to Deploy AI-Powered Battery Storage at UK Facility

Jun 25, 2024

11:30 AM EDT, 06/25/2024 (MT Newswires) -- O-I Glass ( OI ) and GridBeyond plan to implement an 8 megawatt battery storage system at O-I's Alloa, UK facility, supported by an artificial intelligence-driven energy management system, the companies said Tuesday. The system aims to boost energy efficiency, grid resilience, and sustainability by optimizing energy use based on grid conditions, the...

Airbus eyes operations at four Spirit Aero plants, sources say

Jun 25, 2024

PARIS, June 25 (Reuters) - Airbus is poised to take over all or part of the operations of four Spirit AeroSystems ( SPR ) plants as part of an impending deal that involves a carve-up of the U.S.-based aerostructures maker with Boeing ( BA ), industry sources said. As expected, the two main plants involved in the transfer to Airbus...

Looking At Goldman Sachs Gr's Recent Unusual Options Activity

Jun 25, 2024

Deep-pocketed investors have adopted a bearish approach towards Goldman Sachs Gr , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GS usually suggests something big is about to happen. We gleaned this information from our...

Optimi Health Up 7.8% as After Health Canada Go-Ahead to Supply MDMA and Psilocybin to Patients in Australia

Jun 25, 2024

11:30 AM EDT, 06/25/2024 (MT Newswires) -- Optimi Health ( OPTHF ) on Tuesday said it received three export permits from Health Canada to supply MDMA and psilocybin capsules for use in patients participating in Australia's Authorised Prescriber Scheme. Beginning with 160 doses, the licenses mark Optimi's commercial entry into Australia with its GMP (Good Manufacturing Practices) psychedelic medicines for...